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The essential splicing factors U2AF65 and SF1 coop-
eratively bind consensus sequences at the 30 end
of introns. Phosphorylation of SF1 on a highly
conserved ‘‘SPSP’’ motif enhances its interaction
with U2AF65 and the pre-mRNA. Here, we reveal
that phosphorylation induces essential conforma-
tional changes in SF1 and in the SF1/U2AF65/30
splice site complex. Crystal structures of the phos-
phorylated (P)SF1 domain bound to the C-terminal
domain of U2AF65 at 2.29 A˚ resolution and of the
unphosphorylated SF1 domain at 2.48 A˚ resolu-
tion demonstrate that phosphorylation induces a
disorder-to-order transition within a previously
unknown SF1/U2AF65 interface. We find by small-
angle X-ray scattering that the local folding of the
SPSP motif transduces into global conformational
changes in the nearly full-length (P)SF1/U2AF65/30
splice site assembly. We further determine that
SPSP phosphorylation and the SF1/U2AF65 interface
are essential in vivo. These results offer a structural
prototype for phosphorylation-dependent control
of pre-mRNA splicing factors.
INTRODUCTION
Protein phosphorylation is required for pre-mRNA splicing (re-
viewed in Stamm, 2008), yet, to our knowledge, the structural
changes induced by splicing factor phosphorylation currently
are unknown. The serine/arginine-rich (SR) protein superfamily
is a prototype for phosphorylation-dependent control of pre-
mRNA splicing, in which phosphorylation of arginine-serine
repeats regulates the localization and interactions among SR
proteins and the pre-mRNA (reviewed in Ghosh and Adams,
2011). Phosphorylation of other classes of splicing factors isStructure 21, 19only beginning to be understood at the molecular level. One
exemplary function of non-SR phosphorylation is to regulate
interactions with U2AF65, which is an essential pre-mRNA
splicing factor (Golling et al., 2002; Ruskin et al., 1988). A
complex between U2AF65 and a second splicing factor, SF1,
cooperatively recognizes consensus sequences at the 30 splice
sites of pre-mRNAs (Berglund et al., 1998; Zamore et al.,
1992). There, U2AF65 recruits the U2 small nuclear ribonucleo-
protein particle (snRNP) to the assembling spliceosome (Ruskin
et al., 1988). Phosphorylation of SF1 by cGMP-dependent
protein kinase-I (PKG-I) inhibits association with U2AF65 (Wang
et al., 1999). Similarly, the SF3b155 subunit of the U2 snRNP is
phosphorylated adjacent its U2AF65-interaction sites (Boudrez
et al., 2002; Seghezzi et al., 1998), which suggests that
SF3b155 phosphorylation could promote U2AF65 dissociation
from the activated spliceosome (Bessonov et al., 2010; Shi
et al., 2006; Wang et al., 1998).
A highly conserved SPSP motif of human SF1 (residues 80–
83) was found to be predominately in the phosphorylated
state in proliferating human embryonic kidney cells (Manceau
et al., 2006). Subsequent phospho-proteome analyses of
HeLa (Beausoleil et al., 2004), lymphoma (Shu et al., 2004),
and prostate cancer cells (Myung and Sadar, 2012) confirm
the prevalence of SF1 SPSP phosphorylation and suggest
a role in cancer initiation or progression. A kinase called kinase
interacting with stathmin (KIS), or UHMK1, specifically phos-
phorylates SF1 serines at positions 80 and 82 within the
SPSP motif (Manceau et al., 2006, 2008). Phosphorylation
by KIS enhances SF1/U2AF65 interactions and promotes
assembly of the ternary complex among SF1, U2AF65, and
the 30 splice site (Manceau et al., 2006). The phosphorylated
SPSP motif resides in the most highly conserved region of
SF1, which is located between a KH-QUA2 domain for pre-
mRNA recognition and an N-terminal U2AF ligand motif
(ULM) for U2AF65 interactions. Whereas most of the SF1 or
U2AF65 domains engage in well-characterized protein or RNA
interactions during pre-mRNA splicing and belong to docu-
mented families of protein folds (Figure 1A), the SPSP-contain-
ing region of SF1 lacks known structural homologs. Apart from7–208, February 5, 2013 ª2013 Elsevier Ltd All rights reserved 197
Figure 1. SPSP Phosphorylation and
U2AF65 Interactions Are Important for Cell
Proliferation
(A) Schematic diagrams of human SF1 (green) and
U2AF65 (blue) domain organization. The positions
of the ULM tryptophan and phosphorylated
S80/S82 residues are given above the SF1
diagram. Circled ‘‘P’’ (magenta) indicates the
‘‘SPSP’’ phosphorylation sites. KH-QUA2, K
homology and Quaking homology 2 domain; Zn,
zinc knuckle.
(B) SF1 knockdown affects NIH 3T3 cell prolifer-
ation. Top view shows SF1 levels that were
analyzed by western blot (WB) after 48 hr of
treatment with SF1-specific or control unrelated
siRNAs (10 nM). The different SF1 splice isoforms
were detected using an anti-N-terminal SF1
antibody (see Experimental Procedures). b-tubulin
(clone E7, Developmental Studies Hybridoma
Bank) and b-actin (clone AC-15; Sigma-Aldrich)
are included as controls for general protein
levels. Bottom view presents cells that were
counted manually after 72 hr of siRNA treatment.
The histogram shows mean values for two
experiments with each condition tested in tripli-
cate to give a SEM. The ANOVA with Bonferroni
correction is indicated as follows throughout
the figure: *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 104.
(C) Rescue experiments after endogenous SF1
knockdown (SF1-kd) by siRNAs. Different SF1-
expressing vectors were used corresponding to
wild-type (WT) or mutated 80 kDa human SF1
isoformSF1HL1 (themost prevalent splice isoform
in HeLa cells) (Arning et al., 1996; Manceau et al.,
2006). The left panel is a representative phase
contrast view of cells after re-expression of wild-
typeorS80/82Amutant SF1.Histogramshowscell
numbers relative to rescue with wild-type SF1
deduced from 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) staining. Each
mutant was tested for its rescuing ability in
triplicate in six independent experiments. A3 indi-
cates a transfection control of an empty vector.
The lower panel presents a similar expression of
the different SF1 constructs used for the rescue
experiments that was checked by immunoblot with an anti-myc antibody (clone 9E10, Santa Cruz Biotechnology) 24 hr after transfection with the plasmids.
(D) Comparison of the U2AF65 binding abilities of the wild-type and mutant SF1 in the presence and absence of phosphorylation by KIS (+ Kinase). An HEK293T
cell extract was used as a source of U2AF65 for pull-down with the different SF1 isoforms expressed as GST fusion in bacteria (resides 1–255 of human SF1
fused to an N-terminal GST moiety). Each GST-SF1 protein was incubated with ATP and recombinant KIS kinase or buffer alone. Similar results were obtained
when the untreated samples consisted of SF1 incubated with KIS but without ATP (data not shown). The treated proteins were used for pull-down experiments,
and bound U2AF65 was detected by immunoblotting. A total of 0.3% of the input was run in the left lane. Histogram shows the mean values of six experiments
after normalization to the mean of the three highest signals (consistently (P)SF1, 2E, and KIS-treated 2E).
See also Figure S1.
Structure
Structures of Phosphorylated SF1/U2AF65 Complexesphosphorylation, the function of the SF1 SPSP-containing
domain is poorly understood.
Notably, the SF1 SPSPmotif typifies the phosphorylation sites
of U2AF65 interaction partners, which often are found adjacent
to ULM sequence motifs composed of a key tryptophan residue
preceded by arginine and lysine residues. These ULMs bind
RNA recognition motif (RRM) relatives that have acquired
specialized features for ULM recognition, called U2AF homology
motifs (UHMs). The prototypical UHM of U2AF65 sequentially
engages the ULMs of SF1 and SF3b155 during the splicing
process (Cass and Berglund, 2006; Selenko et al., 2003; Spa-198 Structure 21, 197–208, February 5, 2013 ª2013 Elsevier Ltd All rdaccini et al., 2006; Thickman et al., 2006). Subsequent
sequence analyses and a number of structures have identified
UHMs among diverse nuclear proteins, including the KIS kinase,
nuclear lamins, and other pre-mRNA splicing factors (Kielkopf
et al., 2004). The atomic resolution structures of U2AF65,
U2AF35, and SPF45 complexes (Corsini et al., 2007; Kielkopf
et al., 2001; Selenko et al., 2003) reveal shared features of
UHM-ULM recognition. The ULM tryptophan is buried within
a hydrophobic pocket, and positively charged residues interact
with negatively charged residues of the UHM. The short length
of this epitope raises the question of how ULMs specify distinctights reserved
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Structures of Phosphorylated SF1/U2AF65 ComplexesUHMs or whether crosstalk occurs regularly among ULMs and
diverse UHM-containing proteins. For example, the UHMs of
SPF45, PUF60, and KIS kinase bind a range of ULMs, including
those of U2AF65, SF3b155, and SF1 (Corsini et al., 2007, 2009;
Manceau et al., 2008). In contrast, an extended, proline-rich
region of the U2AF65 ULM engages in a specific ‘‘tongue-in-
groove’’ interaction with the U2AF35 UHM (Kielkopf et al.,
2001), indicating that subtle architectural changes can confer
ULM/UHM specificity. In addition to sequence extensions of
the minimal ULM, posttranslational modifications such as phos-
phorylation also offer potential handles to confer specificity in the
ULM-UHM network.
To advance our understanding of the role of phosphorylation in
the SF1/U2AF65 interaction, we determined the structure of the
doubly phosphorylated SPSP domain in the SF1/U2AF65
complex in comparison with unphosphorylated SF1 and further
established that SPSP phosphorylation and U2AF65 interactions
are required for mammalian cell proliferation. Crystal structures
reveal that the phosphorylated domain of human SF1 engages
the U2AF65 UHM in an extensive interface beyond the minimal
ULM. The structure of the unphosphorylated SF1 domain,
coupled with small-angle X-ray scattering (SAXS) of SF1/
U2AF65 complexes in the different phosphorylated and
RNA-bound states, further demonstrated that phosphorylation-
induced folding of an arginine-rich loop around the phosphory-
lated serines amplifies into overall conformational changes in
the nearly full-length, phosphorylated SF1 [(P)SF1]/U2AF65/30
splice site complex. This tightly bent conformation of the phos-
phorylated splicing factor complex is compatible with coupling
of the 50 and 30 ends of the splice site for the catalytic steps of
splicing.
RESULTS
SF1 SPSP Phosphorylation Is Required for Mammalian
Cell Proliferation and Contributes to U2AF65 Binding
To our knowledge, the importance of SF1/U2AF65 interactions
and SPSP phosphorylation for mammalian cell proliferation was
unknown. It was previously demonstrated that SF1 knockdown
in HeLa cells by siRNA transfection substantially reduced cell
proliferation (Tanackovic and Kra¨mer, 2005). We leveraged this
requirement as the basis for testing the importance of SF1 phos-
phorylation andU2AF65 interactions (Figure 1; FigureS1available
online). Proliferation of mouse NIH 3T3 fibroblasts was impaired
severely following transfectionwith three different siRNAs target-
ing the known splice isoforms of mouse SF1 (Figures 1B, S1A,
and S1B). Three days posttransfection, SF1 protein was no
longer evident, and the cell numbers were substantially dimin-
ished compared to two control siRNAs (Figure 1B). We next
tested the abilities of wild-type or myc-tagged SF1 containing
mutated residues within the N terminus (Figure 1A) to rescue
the proliferation of cells treated continuously with siRNA. The
transfected expression plasmids were derived from the human
SF1 cDNA, which encodes an identical protein as mouse SF1
but has the advantage of at least twomismatches with our siRNA
constructs. Accordingly, human SF1 and its mutant forms were
readily detected at similar levels by immunoblotting 24 hr post-
transfection (Figure 1C, lower right panel). The transiently ex-
pressed proteins were phosphorylated efficiently in vivo, withStructure 21, 19the exception of the serinemutations that prevented SPSP phos-
phorylation (Figure S1C). Five days after plasmid transfection,
cell proliferation was measured by cell counting or assessed by
an MTT assay. Wild-type SF1 restored the proliferation potential
and apparent normal morphology of the cells (Figure 1C).
To assess the cellular consequences of abrogating the SF1/
U2AF65 complex, we first tested a tryptophan-to-alanine
(W22A) mutation in the SF1 ULM that is known to disrupt
U2AF65 binding in vitro (Selenko et al., 2003). TheW22Amutation
severely reduced the ability of SF1 to rescue siRNA-treated cells,
which is in agreement with the individual requirements for SF1
and U2AF65 in most eukaryotes tested (for example, Golling
et al., 2002; Kanaar et al., 1993; Mazroui et al., 1999; Potashkin
et al., 1993; Shitashige et al., 2007; Zorio and Blumenthal, 1999).
The deleterious effect of the W22A mutation in SF1 demon-
strated that formation of the SF1/U2AF65 complex is required
for mammalian cell proliferation (Figure 1C). We next tested the
in vivo consequences of mutating the serines in the SF1 SPSP
motif (S80 and S82) that are normally phosphorylated in prolifer-
ating cells. Preventing phosphorylation by mutating the serines
to alanines within the SPSP motif (S80/82A) reduced the ability
of SF1 to rescue cell proliferation to a level comparable to the
W22Amutation, whereas phosphomimeticmutations in themotif
(S80/82E) that introduced a negative charge were significantly
more effective at promoting proliferation than the S80/82A
mutant (Figure 1C). The effects of the SF1 mutations indicated
that both formation of the SF1/U2AF65 complex and phosphory-
lation of the SPSP motif are essential for mammalian cell
proliferation.
Based on the observed in vivo functional importance of SF1
phosphorylation, we correlated the rescuing potential with the
ability of the SF1 proteins to bind U2AF65 (Figure 1D). Nearly
full-length, GST-fused SF1 fragments (comprising the ULM,
SPSP, and KH-QUA2 domains) were purified from E. coli and
incubated in pull-down assays with an HEK293T RNase-treated
cell extract as a source of U2AF65 because endogenous
U2AF65 in these extracts was less prone to aggregation than
the recombinant protein. Each GST-fusion protein was tested
after incubation in a phosphorylation reaction with or without
purified KIS. SDS-PAGE and phosphoprotein staining confirmed
that the proteins were phosphorylated efficiently using these
conditions (Figure 1D). As expected, based on previous observa-
tions (Manceau et al., 2006; Selenko et al., 2003), the critical
W22A mutation nearly abolished association with U2AF65,
whereas phosphorylation of SF1 by KIS increased association
with U2AF65. The phosphorylation-impaired S80/82A mutant
behaved similarly to unphosphorylated wild-type SF1, whereas
the phosphomimetic S80/82E mutant was comparable to
(P)SF1. These in vivo and interaction studies demonstrated that
SPSP phosphorylation is correlated with SF1/U2AF65 complex
formation and is required for mammalian cell proliferation.
Solution Experiments Implicate the SPSP Domain in the
SF1/U2AF65 Interface
Given an evident role for the SPSP domain in forming the SF1/
U2AF65 complex, we proceeded to investigate the size of the
SF1/U2AF65 interface in solution. Because heat capacity
changes (DCp) are often related to interface size (reviewed in
Prabhu and Sharp, 2005), we used isothermal titration7–208, February 5, 2013 ª2013 Elsevier Ltd All rights reserved 199
Figure 2. Solution Evidence for an Extended SF1/U2AF65 UHM
Interface
(A) Comparison of DCp values experimentally determined for SF1 binding
the U2AF65 UHM with that calculated from the minimal SF1 ULM/U2AF65
UHM structure (PDB 1OPI) or a typical protein heterodimer interface (Janin
et al., 2008). Structure-based DCp values were calculated as described in
Supplemental Experimental Procedures.
(B) Representative 15N-1H HSQC spectra of 15N-labeled U2AF65 UHM
complexes with SF1 residues 13–28 (green, ULM), SF1 residues 1–255
(orange, including the ULM, SPSP domain, and KH domain), or SF1 residues
14–132 (blue, including the ULM and SPSP domain). Residues with chemical
shift differences > (hDdi+1s) between the (15N)U2AF65 UHM complexes with
SF1 ULM versus SF11-255 are labeled and closely match the complex with
SF114–132. The difference for (15N)U2AF65 R403 (italicized), which is located
near the N terminus of the SF1 ULM on the opposite face as the bound coiled
coil, is likely due to interactions with additional SF1 residues 1–12 and
preceding GPLGS sequence from the cloning/tag-cleavage site of both
protein constructs. The (15N)U2AF65 residues shown in bold font are mapped
on the SF1 ULM/U2AF65 UHM structure in (C).
(C) Chemical shift changes > (hDdi+1s) (orange) mapped on the ribbon
diagram of U2AF65 UHM (blue) bound to SF1 ULM (green) (PDB 1OPI) (left).
See also Figure S2.
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200 Structure 21, 197–208, February 5, 2013 ª2013 Elsevier Ltd All rcalorimetry at four different temperatures to determine the DCp
for U2AF65 UHM binding to a nearly full-length SF1 protein
containing the conserved ULM, SPSP, and KH-QUA2 domains
(residues 1–255) (Figures 2A and S2A–S2C). The DCp for SF1
binding to the U2AF65 UHM (462 ± 55 cal mol1 K1) corre-
sponded to 1,900 A˚2 of additional buried surface area beyond
the previously established SF1 ULM/U2AF65 UHM interface
(Selenko et al., 2003). This relatively large, unknown interface
between SF1 and the U2AF65 UHM corresponded in size to
a typical heterodimer interface (Janin et al., 2008).
We then compared differences in the 1H-15N HSQC spectra
of 15N-labeled U2AF65 UHM bound to three different SF1
constructs (Figures 2B, 2C, and S2D): the minimal SF1 ULM
peptide, SF114–132 composed of the ULM, and the adjacent
SPSP domain, or nearly full-length SF1. The 1H-15N HSQC spec-
trum of the (15N)U2AF65 UHM/SF1 ULM complex was assigned
based on prior assignments (courtesy of M. Sattler; Selenko
et al., 2003) and extrapolated to the SF1 and SF114–132
complexes with the assistance of 3D NOESY-NHSQC and
TOCSY-NHSQC spectra. The HSQC spectra of SF1/(15N)
U2AF65 UHM and SF114–132/(15N)U2AF65 UHM are nearly iden-
tical, in contrast to the HSQC spectra of the aforementioned
compared with the SF1 ULM/U2AF65 UHM complex, which
differs significantly at UHM residues surrounding the bound
ULM C terminus. These results implicated the SPSP domain of
SF1, which follows the SF1 ULM C terminus, as an additional
region that interacts with U2AF65. Such an extended SF1/
U2AF65 interface explains prior observations that a ULM deletion
mutant of SF1 continues to support spliceosome assembly at
a low but detectable level (Rain et al., 1998).
Structure of the Phosphorylated (P)SF1/U2AF65
Complex
To understand the role for the phosphorylated SPSP domain of
SF1 in complex formation with U2AF65, we determined the
2.29 A˚ resolution crystal structure of the U2AF65 UHM bound
to phosphorylated (P)SF114–132 protein comprising the
N-terminal ULM and SPSP domains (Figure 3; Table 1; Supple-
mental Experimental Procedures). The SPSP domain consists
of two a helices arranged in an antiparallel coiled coil, which
differs from previously classified fold families. A DALI search
(Holm and Sander, 1993) of the Protein Data Bank (PDB) iden-
tified the coiled coil of the endosomal-sorting complex subunit
Vps23 (PDB 2F6M; Kostelansky et al., 2006) as the closest
match among known structures, which only shares 12%
sequence identity, a modest Z score of 5.7, and 3.8 A˚ rmsd
between 60 matching Ca atoms. The ULM is linked to the
SPSP domain by residues running antiparallel to the first helix
of the coiled coil, and the phosphorylated SPSP motif is
located at the junction of the two a helices (Figures 3A and
3B). Apart from slight revisions of the secondary structure
elements (Figures 3C and S3), the core SF1 ULM/U2AF65
UHM structure generally agrees with the NMR structure of
the minimal SF1 ULM/U2AF65 UHM complex (Selenko et al.,
2003) (rmsd 1.4 A˚ for 103 matching Ca atoms of PDB 1O0P).
Additionally, the SF114–132/U2AF65 UHM crystal structure
identified a hydrogen bond that is poorly defined by NMR (Lie-
pinsh et al., 1992), between a conserved serine in the SF1 ULM
(S20) and a conserved aspartate (D401) in the acidic U2AF65ights reserved
Figure 3. Structure and Conservation of the
(P)SF114–132/U2AF65 UHM Complex
(A) Overall structure of (P)SF114–132 bound to the
U2AF65 UHM. A dashed line represents disor-
dered residues. Left view is into the ULM binding
site. Right view is into the SF1 coiled-coil interface
with U2AF65, following a 90 clockwise rotation
about the y axis.
(B) Alignment of SF1 ULM and coiled-coil domain
sequences from Homo sapiens (NCBI RefSeq
NP_004621), Mus musculus (NP_001104261;
99% sequence identity with human SF1 residues
14–132/99% overall identity with full-length
human SF1), Xenopus laevis (NP_001080780;
92/70%), Drosophila melanogaster (NP_524654;
65/44%), Caenorhabditis elegans (NP_503033;
54/37%), Dictyostelium discoideum (XP_629004;
40/22%), Arabidopsis thaliana (NP_199943; 39/
33%), Schizosaccharomyces pombe (NP_587871;
39/33%), and Saccharomyces cerevisiae (NP_
013217; 29/45%). Human SF114–132 secondary
structures are indicated above the aligned
sequences. Residues with 40%–60% sequence
identity among the homologs are colored yellow,
60%–80% cyan, and 80%–100% green. The
amino acids tested by site-directed mutagenesis
are given in red font above the sequence. Resi-
dues involved in SF1/U2AF65 interface are marked
above the sequence by ‘‘m’’ or ‘‘s’’ for main-chain
or side-chain hydrogen bonds and ‘‘o’’ for hydro-
phobic contacts. The ULM, SPSP motif and
arginine claw are underlined and labeled below
in bold font.
(C) Alignment of U2AF65 UHM sequences from
Homo sapiens (NCBI RefSeq NP_009210), Mus
musculus (NP_001192160; 100% sequence iden-
tity with human U2AF65 residues 375–475/99%
overall identity with full-length human U2AF65),
Xenopus laevis (NP_001080595; 94/92%),
Drosophila melanogaster (NP_476891; 72/81%),
Caenorhabditis elegans (NP_001022967; 67/
54%), Dictyostelium discoideum (XP_637725;
36/41%), Arabidopsis thaliana (NP_195387; 48/
41%), Schizosaccharomyces pombe (NP_595396;
34/29%), and Saccharomyces cerevisiae (NP_
012849; 25/15%), colored as in (B). Residues
corresponding to the RNP2 and RNP1 motifs are
outlined in bold font, and consensus RNP motifs
of canonical RRMs are given below: o, aliphatic; f,
aromatic; x, any residue; +, positive charged; L,
leucine; G, glycine.
See also Table 1 and Figure S3.
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Structures of Phosphorylated SF1/U2AF65 ComplexesUHM a helix (a2) (Figure 4A). Unfavorable electrostatic repul-
sion explains the ability of S20 phosphorylation by PKG-I to
dissociate the SF1/U2AF65 complex and inhibit spliceosome
assembly (Wang et al., 1999).
An SF1 Coiled Coil Mediates an Interface with U2AF65
The (P)SF114–132/U2AF65 UHM structure revealed that the
phosphorylated SPSP domain embraces the U2AF65 UHM in
an a-helical extension of the ULM (Figures 3 and 4). The
C-terminal edge of the U2AF65 UHM b sheet engages in anStructure 21, 19interface with the first a1 helix, preceding loop, and to a minor
extent the a2 helix of SF1. The SF1/U2AF65 interface is corrobo-
rated by the DCp and chemical shift changes for complex forma-
tion in solution. The buried surface area of the (P)SF114–132/
U2AF65 UHM structure accounts for the observed DCp
(1,400 A˚2; 2,200 A˚2 including the ULM) (Figure S2C). Likewise,
the interactions in the structure match substantial differences
in the 1H-15N HSQC spectra of 15N-labeled U2AF65 UHM bound
to either SF1 or SF114–132 compared with the minimal (15N)
U2AF65 UHM/SF1 ULM complex (Figure S2D).7–208, February 5, 2013 ª2013 Elsevier Ltd All rights reserved 201
Table 1. Crystallographic Data and Refinement Statistics
(P)SF114–132/U2AF65 UHM SF114–132
Data collectiona
Space group C2221 C2
Unit cell
a 76.8 96.0
b 116.1 38.0
c 130.0 144.7, b = 107.4
Data Set Remote Inflection Peak High Resolution Native
Wavelength (A˚) 0.9219 0.9794 0.9793 0.9219 0.9794
Resolution (A˚) 50–2.80 50–2.85 50–2.85 45–2.29 50–2.48
Rsym (%)
b 6.6 (47.0) 9.2 (42.4) 9.5 (45.0) 6.2 (37.9) 10.8 (26.0)
<I/s(I)> 18.8 (3.0) 14.8 (3.1) 14.7 (2.7) 28.9 (1.9) 4.5 (1.9)
No. of unique reflections 27,317 25,900 26,044 50,161 16,211
Completeness (%) 99.5 (98.3) 99.5 (98.9) 99.5 (97.8) 99.6 (99.7) 89.2 (75.4)
Multiplicity (%) 3.8 (3.5) 3.9 (3.5) 3.9 (3.5) 4.4 (3.0) 5.1 (5.3)
(P)SF114–132/U2AF65 UHM SF126–132
Refinement
PDB 4FXW 4FXX
Resolution range (A˚) 35–2.29 35–2.48
Rwork/Rfree (%)
c 23.7/27.0 23.8/26.9
No. of atoms
Protein/solvent 3,339/71 2,864/124
Anisotropic scale matrix
B11 47.6 8.8
B22 27.4 6.3
B33 20.2 2.5
TLS 22 Groups –
B factors (A˚2)
Protein/solvent 105/102 46/49
Rmsds
Bond lengths (A˚)/angles () 0.003/0.66 0.01/0.87
Ramachandran (%)d
Favored/allowed/outliers 96.3/3.2/0.5 97.1/2.9/0.0
aValues from the highest-resolution shell are given in parentheses. The SeMet MAD data for (P)SF114–132/U2AF65 UHM were collected from a single
crystal and a high-resolution data set from a different crystal. Details of SF114–132 data collection are given in Gupta and Kielkopf (2011).
bRsym =
P
hkl
P
ijIi  <I> j/
P
hkl
P
i Ii, where I is an intensity I for the ith measurement of a reflection with indices hkl, and <I> is the weighted mean of all
measurements of I.
cRwork = ShkljjFobs(hkl)jjFcalc(hkl)jj)/ShkljFobs(hkl)j for the working set of reflections; Rfree is Rwork for 8%of the reflections excluded from the refinement.
All data from the available resolution ranges were used in the refinement.
dCalculated using the program MolProbity (Davis et al., 2004).
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Structures of Phosphorylated SF1/U2AF65 ComplexesConsistent with the large negative DCp (Prabhu and Sharp,
2005), the interface of the SF1 SPSP domain with U2AF65 is
primarily hydrophobic. In the loop preceding the coiled coil,
SF1 V39 and I40 contact U2AF65 M446 and M381/V460 resi-
dues, respectively (Figure 4C). In the SF1 a1 helix, I53 and L56
pack against U2AF65M381 and V460, whereas SF1 L56 contacts
U2AF65 V458. Otherwise, the SF1 D60 in the a1 helix forms a salt
bridge with U2AF65 K453, and SF1 E108, which is the sole inter-
acting residue in the SF1 a2 helix, engages U2AF65 R457 (Fig-
ure 4B). The SF1 R46 guanidinium group further encloses the
C-terminal U2AF65 W475 in a cation-p interaction (Figure 4D).
This SF1 R46 interaction induces U2AF65 W475 and the202 Structure 21, 197–208, February 5, 2013 ª2013 Elsevier Ltd All rpreceding F474 residue to mask U2AF65 F433, a singular
example of a conserved UHM residue that would typically stack
against nucleobases bound to canonical RRMs (Figure S3)
(Maris et al., 2005).
The SF1/U2AF Interface Is Essential In Vivo
Based on the structure, we investigated the importance of the
SF1/U2AF65 interface in vivo and in vitro starting with mutation
of the highly conserved, hydrophobic I40 and I53 residues in
the SPSP domain to arginines (I40/53R mutant) (Figures 1C
and 1D). Although the I40/53R mutation did not impair SF1 as
severely as W22A, the I40/53R mutation still substantiallyights reserved
Figure 4. Interface of the (P)SF114–132/U2AF65 UHM Complex
(A) Interactions between the SF1 ULM and the U2AF65 UHM, viewed in
a similar orientation as the left panel of Figure 3A. In (A)–(D), transparent
surface models represent side-chain packing interactions; dashed lines indi-
cate hydrogen bonds or salt bridges. Residues tested following site-directed
mutagenesis are colored yellow. Secondary structure elements of the inter-
acting regions are marked in italicized font.
(B) Hydrogen bonds and ionic interactions between SF1 coiled coil or
preceding loop and the U2AF65 UHM, viewed in a similar orientation as the
right panel of Figure 3A.
(C) Hydrophobic contacts between SF1 coiled coil or preceding loop with the
U2AF65 UHM, viewed in a similar orientation as (B).
(D) The C-terminal U2AF65 W475 buries RNP residues C379, K431, and F433
(magenta, underlined font) and engages in cation-p interactions with R46 of
SF1, viewed following an approximately 2-fold rotation about the y axis relative
to (A).
(E) Schematic diagram of (P)SF114–132/U2AF65 UHM interactions. Residues
involved in hydrogen bonds or salt bridges are enclosed in squares and
connected by short or long dashes for side-chain or main-chain hydrogen
bonds, respectively. Residues involved in packing interactions are enclosed
in ovals and connected by solid lines.
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Structures of Phosphorylated SF1/U2AF65 Complexesinhibited cell proliferation when transfected in siRNA-treated
cells and reduced SF1 association with U2AF65. We separately
replaced the R46 residue that caps the U2AF65 tryptophan
with aspartate and found that this R46D mutation substantially
reduced the interaction with U2AF65 relative to wild-type SF1
(Figure 1D). The inhibitory effects of the I40/53R and R46DStructure 21, 19mutants demonstrate the functional importance of the extended
SF1/U2AF65 interface. Furthermore, these mutations prevented
phosphorylation from affecting the association of SF1 with
U2AF65, which suggests that the effects of phosphorylation
depend on the integrity and coordination among different struc-
tural elements in the N terminus of SF1.
Phosphorylation Induces an Arginine Claw Surrounding
the Phosphorylated SPSP Motif
The phosphorylated SPSP sequence is located in a loop con-
necting the two antiparallel a helices of the SF1 coiled coil
(Figures 2A and 5A). Three conserved arginines, located across
from the phosphates either in the loop preceding the a2 helix
(R93, R97) or in the first turn of this helix (R100), enclose the
phosphorylated (P)S80 and (P)S82 serines of the SPSP motif in
a positively charged, molecular ‘‘claw.’’ In addition, the positively
charged side chains of K104 and R79 are localized near the
phosphates. Interactions with the (P)S80 phosphoryl group
stabilize the R79 conformation, such that the hydrophobic
portion of the R79 side chain packs against the well-defined
R97 side chain. The absence of direct contacts between the
U2AF65 UHM and the phosphorylated serines suggested that
phosphorylation instead could serve as a molecular buttress to
stabilize the fold of the SF1 coiled coil. To test this possibility,
we compared the thermostability of the unmodified and (P)SF1
domain by monitoring changes in the circular dichroism spectra
as a function of temperature (Figure S4C). We found that SPSP
phosphorylation significantly increases the thermostability of
the SF1 domain, consistent with phosphorylation-dependent
stabilization of the SF1 coiled-coil structure for U2AF65 UHM
interactions.
To understand the local conformational changes induced by
SPSP phosphorylation, we determined the complementary
structure of the unphosphorylated SF1 domain (residues 26–
132, SF126–132) at 2.48 A˚ resolution (Table 1). Whereas the
coiled-coil region remains essentially the same (rmsd 0.50–
0.68 A˚ between Ca atoms of residues 46–66/97–115 of the
unmodified versus phosphorylated structures, range given
among crystallographically independent copies), the conforma-
tion of the SPSP loop differs dramatically (Figure 5B). In contrast
to (P)SF114–132 (Figure 5C), residues immediately preceding the
unmodified SPSP motif (residues 74–81) exhibit little detectable
electron density in the absence of phosphorylation (Figure 5D).
Whereas S80 is absent in all four SF126–132 copies in the crystal-
lographic asymmetric unit, the S82 residue is absent in two of the
copies and exposed to solvent in the other two molecules. Anal-
ysis of the SF126-–32 crystals by SDS-PAGE confirmed that the
crystallized protein is intact (Figure S4B). Although the structural
disorder potentially could be due to the lack of an interaction
partner rather than phosphorylation, the SPSP-containing loop
does not directly participate in the interface with the U2AF65
UHM. Furthermore, SF1 residues 74–81, R93, R97, and R100
are free of crystal packing contacts among the structures. As
such, the unphosphorylated SPSP motif appears to be highly
flexible. The release of R97 from interactions with the (P)S80
phosphoryl group leads to disorder in the arginine side chain,
as well as surrounding residues such as the R79 side chain.
Taken together, phosphorylation appears to induce local folding
of residues preceding and partially including the SPSP motif.7–208, February 5, 2013 ª2013 Elsevier Ltd All rights reserved 203
Figure 5. SF1 Phosphorylation Induces an
Arginine Claw to Surround the SPSP Motif
(A) Ordered arginine residues enclose the phos-
phorylated (P)S80 and (P)S82 in the SPSP motif of
SF1. Residues altered bymutagenesis are colored
yellow.
(B) Superposition of the four apo-SF126–132 copies
in the asymmetric unit (green) and two phosphor-
ylated (P)SF114–132 copies (purple) by matching
Ca atoms in a similar orientation as (A). The
SF1 ULMs (pink) lack corresponding residues in
the apo-SF126–132 construct.
(C and D) Maximum-likelihood weighted, aver-
aged kicked maps contoured at 1.0 s level
surrounding residues 71–100 of (C) the refined (P)
SF114–132 or (D) apo-SF126–132 coordinates. Resi-
dues P74–P81 are disordered in the apo structure
and are indicated by a dashed line.
See also Figure S4.
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Structures of Phosphorylated SF1/U2AF65 ComplexesPhosphorylation of the SPSP Loop Contributes to
SF1/U2AF65 Complex Formation and Is Essential In Vivo
We next tested the in vivo and in vitro importance of (P)S80 and
(P)S82 interactions with the arginine ‘‘claw’’ bymutating the R93,
R97, and R100 arginines of SF1 to glutamate (R93/97/100E
mutant) (Figure 1). The R93/97/100E mutation of SF1 reduced
cell proliferation to a comparable level as preventing SPSP
phosphorylation with the S80/82A mutation. In the absence of
phosphorylation, the U2AF65 interactions of the R93/97/100E
mutant remained similar to the wild-type SF1. Instead, the
R93/97/100E mutation interfered with the ability of SPSP
phosphorylation to enhance U2AF65 interactions, which were
reduced drastically when comparing the phosphorylated (P)
R93/97/100E and wild-type (P)SF1 proteins. The combined
results from these structural and functional experiments demon-
strate that the arginine ‘‘claw’’ is imperative for sensing and
transmitting the phosphorylation state of the SPSP motif for
formation of the SF1/U2AF65 complex.
SPSP Phosphorylation Promotes a ‘‘C’’-Shaped
(P)SF1/U2AF65/RNA Complex
To investigate whether phosphorylation alters the overall con-
formation of the early 30 splice site complex, we used SAXS
to characterize the solution shapes of nearly full-length phos-
phorylated and unphosphorylated SF1 (residues 1–255) and
U2AF65 (residues 148–475) either as protein complexes or
bound to a prototypical 30 splice site from the adenovirus major
late (AdML) pre-mRNA (Figures 6, S5, and S6; Table S1). The
phosphorylation state, stoichiometry, and monodisperse nature
of the samples were verified as described in the Supplemental
Experimental Procedures and shown in Figures S5 and S6.
Because the bound RNAs contribute approximately 10% of204 Structure 21, 197–208, February 5, 2013 ª2013 Elsevier Ltd All rights reservedthe total scattering mass, the scattering
data primarily reflect the conformations
of the protein components.
Phosphorylation of the SF1 SPSPmotif
induced striking conformational changes
in the (P)SF1/U2AF65/RNA complex.
Whereas phosphorylation of the SPSPmotif already causes the maximum dimensions determined
in pairwise distance distribution (P(r)) functions to decrease
slightly (from 150 A˚ for SF1/U2AF65 to 135 A˚ for (P)SF1/U2AF65
complexes), phosphorylation significantly compresses the (P)
SF1/U2AF65/RNA complex to a maximum dimension of 110 A˚
(Figure 6C; Table S1). We further investigated the nature of the
conformational changes in three dimensions by comparing
averaged and filtered ab initio restorations of the scattering
data (Figures 6D and S6). From a relatively ellipsoidal arrange-
ment of tandem domains in the SF1/U2AF65 or (P)SF1/U2AF65
complexes, the (P)SF1/U2AF65/RNA complex converts to a
nearly uniform ‘‘C’’ shape following SPSP phosphorylation.
These differences demonstrated that SPSP phosphorylation
exacerbates global conformational changes in the ternary (P)
SF1/U2AF65/RNA complex.
DISCUSSION
In this study, we have established that a coiled-coil structure
within the SF1 SPSP domain provides an extended interface to
bind U2AF65, which is required for mammalian cell proliferation.
Phosphorylation of the SPSP motif in the coiled-coil domain
induces local folding and induces global rearrangements in the
SF1/U2AF65/RNA complex. Taken together, these structural
and functional results support a model whereby phosphorylation
indirectly facilitates SF1/U2AF65 interaction by ordering the
SPSP motif, which in turn favors the coordinated contribution
of the N-terminal ULM peptide and coiled-coil SF1 domains at
the U2AF65 interface. This phosphorylated extension of the
SF1/U2AF65 UHM interface beyond the short ULM epitope rai-
ses the possibility that domains adjoining the minimal U2AF65,
SF1, and SF3b155, or other, as yet uncharacterized ULMs, could
Figure 6. Phosphorylation Induces Global Conformational Changes in the SF1/U2AF65/RNA Complex
(A) Domain boundaries and AdML splice site sequences used for SAXS experiments.
(B) X-Ray scattering profiles of the final merged scattering data (colored circles) compared with data calculated from the 3D ab initio reconstruction with the
lowest NSD (black lines). For (A)–(C), the complexes are identified by color as follows: SF1/U2AF65, light green; (P)SF1/U2AF65, cyan; SF1/U2AF65/RNA, dark
green; (P)SF1/U2AF65/RNA, magenta.
(C) Pairwise-distance distribution functions demonstrate large changes in the maximum dimensions of the SF1/U2AF65 complex following phosphorylation. The
(P)SF1/U2AF65/RNA P(r) plot was scaled to a maximum value of one, and the integrated areas of all other curves were scaled to the normalized (P)SF1/U2AF65/
RNA P(r) plot. The radii of gyration (RG) and maximum intraparticle sizes (Dmax) are listed in Table S1.
(D) Averaged and filtered 3D ab initio molecular envelopes resulting from ten iterations of DAMMIN (Svergun, 1999). Complexes are viewed following super-
position using SUPCOMB (Kozin and Svergun, 2001).
(E) Schematic model of the SF1/U2AF65/30 splice site complex.
See also Table S1 and Figures S5 and S6.
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Structures of Phosphorylated SF1/U2AF65 Complexesserve common roles in regulating the UHM network or, more
broadly, pre-mRNA splicing factor activity.
The local disorder-order transition and ensuing global con-
formational changes of the phosphorylated SPSP motif of SF1
bear striking resemblance to the well-characterized example
of protein kinases (reviewed in Taylor and Kornev, 2011). Phos-Structure 21, 19phorylation of protein kinase activation loops is a rare structural
view of protein conformational changes induced through this
modification. As exemplified by the prototype of cAMP-depen-
dent protein kinase, phosphorylation shifts a disordered or vari-
able loop to adopt a well-defined structure that is conserved
among diverse families of protein kinases. Localized folding of7–208, February 5, 2013 ª2013 Elsevier Ltd All rights reserved 205
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Structures of Phosphorylated SF1/U2AF65 Complexesthe kinase activation loop depends on electrostatic interactions
between the phosphorylated side chain and a key arginine
residue. In turn, the phosphorylation-dependent relocation of
the arginine shifts neighboring residues and promotes interdo-
main closure to achieve active conformation of the kinase. As re-
vealed by our structures of the (P)SF1/U2AF65 UHM complex
compared to unphosphorylated SF1, the activation of protein
kinases is analogous to SPSP phosphorylation in the SF1/
U2AF65 complex. We have shown that phosphorylation of SF1
induces (1) local folding of the SPSPmotif, (2) arginine side-chain
relocation, and (3) global domain closure in an analogous
manner to protein kinase activation.
The ‘‘C’’-shaped morphology of the (P)SF1/U2AF65/RNA
complex observed here is consistent with a bent confor-
mational model of the 30 splice site during the early stages of
spliceosome assembly (Figure 6E). Our model accounts for
known chemical interactions, as well as functional require-
ments, and places these features into a physical context. The
fact that the 50 and 30 splice sites communicate in the early
splicing factor complex is exemplified by the association of
the U1 snRNP at the 50 splice site, which facilitates association
of U2AF65 (Michaud and Reed, 1993) and subsequently the U2
snRNP at the 30 splice site (Barabino et al., 1990). Moreover,
the close proximity of the branchpoint sequence, the 50 splice
site, and the 30 splice site during early spliceosome assembly
has been postulated based on hydroxyl radical probing (Kent
and MacMillan, 2002). Association of U2AF65 with the assem-
bling spliceosome appears to provide sufficient driving force
to promote interactions among sequences in the 30 part of
the intron (Kent et al., 2003). Accordingly, the arginine/serine-
rich (RS) domain of U2AF65 contacts pre-mRNA sequences
located both upstream and downstream of the 30 splice site
(Kent et al., 2003; Shen and Green, 2004; Valca´rcel et al.,
1996). Significantly, the ‘‘C’’-shaped conformation of the (P)
SF1/U2AF65/RNA complex would juxtapose the 50 and 30
boundaries of the splice site in preparation for nucleophilic
attack by the branchpoint sequence in the first catalytic step
of pre-mRNA splicing (Figure 6E). Our data demonstrate that
phosphorylation of the SF1 SPSP motif works synergistically
with other domains or RNA to promote the bent organization
of the SF1/U2AF65/30 splice site complex. An important future
goal is to determine the molecular pathway whereby SPSP
phosphorylation prepares the (P)SF1/U2AF65/30 splice site
conformation for the early stages of pre-mRNA splicing.
EXPERIMENTAL PROCEDURES
siRNA Transfections
NIH 3T3 cells were maintained in DMEM containing 10% fetal calf serum in
a humidified incubator and 5% CO2 at 37
C. The cells were seeded in 35 mm
dishes at a density of 30,000 cells/dish with 2.5 ml of medium and trans-
fected the next day (day 1) by adding 30 pmol of siRNA and 4 ml of
Lipofectamine RNAiMAX in 0.5 ml of Opti-MEM following the manufacturer’s
instructions (Invitrogen). On day 4, cells were trypsinized and counted
after trypan blue staining. Extracts were prepared from cell pellets and
analyzed by SDS-PAGE and immunoblotting (Figure S1B). The siRNAs
used were all Stealth siRNAs from Invitrogen: siSF1-1, 50-GCTTCGAGAG
TTGGCTCGCTTGAAT-30; siSF1-2, 50-GCTCAGGATAAAGCACGGATGGAT
A-30; siSF1-3, 50-GAGAAGGAATGCAACGCCAAGATCA-30; siCTL1, GFP
Reporter Control (Invitrogen); and siCTL2, 50-GCUAGAGUGGUCGCUCGU
UGCUAAU-30.206 Structure 21, 197–208, February 5, 2013 ª2013 Elsevier Ltd All rRescue Experiments
NIH 3T3 cells were seeded in 35 mm dishes at a density of 50,000 cells/dish
and transfected with siRNA siSF1-1 (day 1). On day 4, the cells were split
and reverse transfected with siSF1-1 at a density of 5,000 cells/100 ml of
medium per well in 96-well plates. On day 5, cells were transfected with SF1
(Manceau et al., 2006) or mutant expression plasmids with Lipofectamine
2000. Cells were incubated with siRNA siSF1-1 for a third time on day 8. On
day 11, cells were stained with CellTiter 96 AQueous One Solution Cell Prolif-
eration Assay (Promega) for 1 hr at 37C in a 5%CO2 humidified incubator, and
absorbance at 490 nm was measured on a Victor3 Multilabel Counter
(PerkinElmer).
Purification and Phosphorylation of Recombinant Proteins
Human U2AF65 (residues 148–475 of NCBI RefSeq NP_009210), DRRM1 (resi-
dues 258–475), UHM (residues 375–475), SF1 (residues 1–255 of NCBI RefSeq
NP_004621), SF114–132 (residues 14–132), and SF126–132 (residues 26–132)
were expressed as recombinant GST-tagged proteins using E. coli strain
BL21 cells. The GST tag was cleaved using PreScission Protease (GE
Healthcare). The SF1 proteins were phosphorylated using KIS kinase in similar
conditions as previously described (Maucuer et al., 2000). Phosphorylation
was verified by shifted mobility on SDS-PAGE gels and by Pro-Q Diamond
phosphoprotein gel stain (Invitrogen) (Figures S1C, S4A, and S5A). Details of
recombinant protein production are provided in the Supplemental Experi-
mental Procedures.
GST Pull-Down Assays
Before performing the pull-down assays, the GST-fusion proteins were
incubated with or without purified KIS kinase in kinase assay conditions
as previously described (Manceau et al., 2006). The phosphorylation effi-
ciency was monitored by SDS-PAGE and Pro-Q Diamond phosphoprotein
stain (Figure S1D). The GST-SF1 fusion proteins were immobilized on gluta-
thione beads and incubated with 293T cell extracts for pull-down of endog-
enous U2AF65. Proteins were detected by immunoblotting. Details of the
GST pull-down procedures are provided in the Supplemental Experimental
Procedures.
DCp and NMR Analyses
Procedures for DCp determination and NMR analyses are provided in the
Supplemental Experimental Procedures.
Crystallographic Analyses
The (P)SF114–132/U2AF65 UHM structure was determined by a three-
wavelength Se-Met multiwavelength anomalous dispersion (MAD) experi-
ment resulting in a figure of merit of 0.68 before density modification. A
high-resolution data set from a separate crystal was used for structure
refinement (Table 1). The SF126–132 structure was determined by molecular
replacement using PHENIX (Adams et al., 2010). Details of protein crystalli-
zation and structure determination are provided in the Supplemental Exper-
imental Procedures.
SAXS Experiments
SAXS sample preparation and data collection at the Advanced Light Source
followed procedures as described (Gupta et al., 2011). Samples were mono-
disperse and free of detectable aggregation based on scattering curves,
Porod volumes, and linear Guinier plots (Figure S5D). A separate series of
SAXS data was collected at the Cornell High Energy Synchrotron Source for
independently prepared (P)SF1/U2AF65 and (P)SF1/U2AF65/RNA complexes
and produced similar results (Figure S6). Details of the SAXS procedures are
provided in the Supplemental Experimental Procedures. Molecular dimen-
sions derived from the SAXS data and discrepancy values of the fitting proce-
dure are reported in Table S1.
ACCESSION NUMBERS
Coordinates and structure factors have been deposited in the Protein Data
Bank with accession codes 4FXW for (P)SF114–132/U2AF65 UHM and 4FXX
for SF126–132. The SAXS data and models have been deposited in BIOISIS
with the accession codes reported in Table S1.ights reserved
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